CSIMarket
 


Janone Inc   (JAN)
Other Ticker:  
 

Janone Inc 's Quick Ratio

JAN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Janone Inc 's Cash & cash equivalent grew by 144.38 % in the III Quarter 2023 sequentially, while Current Liabilities decreased, this led to improvement in Janone Inc 's Quick Ratio to 0.16, above Janone Inc average Quick Ratio.

Within Major Pharmaceutical Preparations industry 454 other companies have achieved higher Quick Ratio than Janone Inc in third quarter 2023. While Quick Ratio total ranking has improved so far during the III Quarter 2023 to 3284, from total ranking in the second quarter 2023 at 3954.

Explain Quick Ratio?
How much Cash & cash equivalents JANīs has?
What are JANīs Current Liabilities?


JAN Quick Ratio (Sep 30 2023)
III. Quarter
(Jul 01 2023)
II. Quarter
(Apr 01 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Oct 01 2022)
III. Quarter
Y / Y Current Liabilities Change -87.07 % -85.05 % -83.09 % 23.56 % -5.91 %
Y / Y Cash & cash equivalent Change -41.42 % -76.03 % -84.74 % -83.69 % -75 %
Quick Ratio MRQ 0.16 0.06 0.1 0 0.04
JAN's Total Ranking # 3284 # 3954 # 3565 # 4727 # 3987
Seq. Current Liabilities Change -13.57 % -16.68 % -85.47 % 23.56 % 0 %
Seq. Cash & cash equivalent Change 144.38 % -52.12 % 206.96 % -83.69 % 0 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 455
Healthcare Sector # 910
Overall Market # 3284


Quick Ratio Statistics
High Average Low
0.29 0.11 0
(Apr 03 2021)   (Dec 31 2022)




Financial Statements
Janone Inc 's Current Liabilities $ 3 Millions Visit JAN's Balance sheet
Janone Inc 's Cash & cash equivalent $ 0 Millions Visit JAN's Balance sheet
Source of JAN's Sales Visit JAN's Sales by Geography


Cumulative Janone Inc 's Quick Ratio

JAN's Quick Ratio for the trailling 12 Months

JAN Quick Ratio

(Sep 30 2023)
III. Quarter
(Jul 01 2023)
II. Quarter
(Apr 01 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Oct 01 2022)
III. Quarter
Y / Y Current Liabilities TTM Growth -87.07 % -85.05 % -83.09 % 23.56 % -5.91 %
Y / Y Cash & cash equivalent TTM Growth -41.42 % -76.03 % -84.74 % -83.69 % -75 %
Quick Ratio TTM 0.03 0.03 0.03 0.05 0.06
Total Ranking TTM # 2796 # 2909 # 3707 # 5377 # 3734
Seq. Current Liabilities TTM Growth -13.57 % -16.68 % -85.47 % 23.56 % 0 %
Seq. Cash & cash equivalent TTM Growth 144.38 % -52.12 % 206.96 % -83.69 % 0 %


On the trailing twelve months basis In spite of the year on year decrease in JAN's Current Liabilities to $2.50 millions, cumulative Quick Ratio to 0.03 below the JAN average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 454 other companies have achieved higher Quick Ratio than Janone Inc . While Quick Ratio overall ranking has improved so far to 2796, from total ranking during the twelve months ending second quarter 2023 at 2909.

Explain Quick Ratio?
How much Cash & cash equivalents JANīs has?
What are JANīs Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 455
Healthcare Sector # 911
Within the Market # 2796


trailing twelve months Quick Ratio Statistics
High Average Low
0.17 0.09 0.03
(Sep. 30, 2013)  




Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2023 MRQ Cash & cash equivalentSep 30 2023 MRQ Current Liabilities
Evelo Biosciences Inc   0.43 $ 17.262  Millions$ 39.761  Millions
Blue Water Biotech Inc   0.43 $ 7.654  Millions$ 17.645  Millions
Integrated Biopharma Inc  0.42 $ 2.594  Millions$ 6.197  Millions
Sonnet Biotherapeutics Holdings Inc   0.41 $ 2.274  Millions$ 5.525  Millions
Avid Bioservices Inc   0.41 $ 31.424  Millions$ 76.937  Millions
Optinose Inc   0.41 $ 66.845  Millions$ 163.981  Millions
Elanco Animal Health Inc  0.41 $ 369.000  Millions$ 909.000  Millions
Societal Cdmo Inc   0.40 $ 8.156  Millions$ 20.524  Millions
Ironwood Pharmaceuticals inc   0.39 $ 110.164  Millions$ 280.579  Millions
Tonix Pharmaceuticals Holding Corp   0.39 $ 6.914  Millions$ 17.733  Millions
Abbvie inc   0.38 $ 13,290.000  Millions$ 34,773.000  Millions
Lftd Partners Inc   0.38 $ 3.125  Millions$ 8.197  Millions
Merck and Co Inc   0.38 $ 8,773.000  Millions$ 23,094.000  Millions
Earth Science Tech Inc   0.37 $ 0.188  Millions$ 0.509  Millions
Sellas Life Sciences Group Inc   0.36 $ 4.069  Millions$ 11.269  Millions
Paxmedica Inc   0.35 $ 1.153  Millions$ 3.271  Millions
Qualigen Therapeutics Inc   0.35 $ 2.074  Millions$ 5.957  Millions
Cingulate Inc   0.35 $ 1.986  Millions$ 5.732  Millions
Bristol myers Squibb Company  0.33 $ 7,839.000  Millions$ 23,462.000  Millions
Entrada Therapeutics Inc   0.31 $ 51.882  Millions$ 165.433  Millions
International Stem Cell Corporation  0.31 $ 1.430  Millions$ 4.682  Millions
Aytu Biopharma Inc   0.30 $ 19.964  Millions$ 65.463  Millions
Flora Growth Corp   0.29 $ 4.798  Millions$ 16.582  Millions
Cv Sciences Inc   0.27 $ 1.643  Millions$ 6.061  Millions
Advaxis Inc   0.26 $ 2.225  Millions$ 8.527  Millions
Jaguar Health inc   0.26 $ 3.226  Millions$ 12.456  Millions
Nighthawk Biosciences inc   0.25 $ 6.210  Millions$ 24.488  Millions
Eli Lilly And Company  0.24 $ 2,493.900  Millions$ 10,475.900  Millions
Cns Pharmaceuticals Inc   0.22 $ 0.910  Millions$ 4.069  Millions
Prophase Labs Inc   0.20 $ 3.267  Millions$ 16.406  Millions

Date modified: 2023-11-17T14:59:37+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright Đ 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com